METHODS AND SYSTEMS FOR FUNCTIONAL MATURATION OF iPSC AND ESC DERIVED CARDIOMYOCYTES
US-2024076619-A1 · Mar 7, 2024 · US
Acellularized biomaterial from embryonic stem cells
US9211307B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9211307-B2 |
| Application number | US-9286306-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 8, 2006 |
| Priority date | Nov 8, 2005 |
| Publication date | Dec 15, 2015 |
| Grant date | Dec 15, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compositions containing acellularized biomaterial derived from differentiating pluripotent cells, for example, embryonic stem cells are provided. The acellularized biomaterial can be used to promote wound healing, promote tissue regeneration, or inhibit scarring. Methods for using the acellularized biomaterial for treating degenerative diseases are also provided.
First claim
Opening claim text (preview).
We claim: 1. A composition comprising acellularized embryoid-body-biomaterial comprising a combination of paracrine factors produced by one or more differentiating embryoid bodies in an amount effective to promote or induce wound healing relative to a control. 2. The composition of claim 1 , wherein the one or more differentiating embryoid bodies undergo cardiac differentiation, neural differentiation, myogenic differentiation, epidermal differentiation, or a…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K35/34Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9211307B2 cover?
- Compositions containing acellularized biomaterial derived from differentiating pluripotent cells, for example, embryonic stem cells are provided. The acellularized biomaterial can be used to promote wound healing, promote tissue regeneration, or inhibit scarring. Methods for using the acellularized biomaterial for treating degenerative diseases are also provided.
- Who is the assignee on this patent?
- Mcdevitt Todd Christopher, Nair Rehka Ramachandran, Georgia Tech Res Inst
- What technology area does this patent fall under?
- Primary CPC classification A61K35/34. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).